WP. CJC-1295 (with DAC) 5 MG

CJC-1295 with DAC is a modified analogue of growth hormone releasing hormone (GHRH) designed with Drug Affinity Complex (DAC) technology to extend its half-life in the body. It has been studied for its potential ability to support natural growth hormone signaling and related metabolic and recovery processes. Potential Benefits - May support sustained growth hormone release - Promotes recovery and tissue repair processes - May support lean muscle development pathways - Supports healthy fat metabolism - May contribute to improved sleep quality - Supports cellular regeneration and recovery signaling - May help promote overall metabolic and physical performance CJC-1295 (with DAC) has attracted interest in peptide research due to its extended activity and its potential role in supporting natural growth hormone signaling over longer durations.